Tuesday, 31 July 2007

Cephalon posts loss on higher costs, generics

(Reuters) - Excluding items, Cephalon had adjusted income of $1.14 per
share, down from $1.51 for the year-ago quarter.





Read more at Reuters.com Market News

No comments: